← Back to all trials
Not Yet Recruiting
NCT07925502
Post Market Clinical Follow-Up Registry Study of the aXess Hemodialysis Conduit
Conditions: End Stage Renal Failure, Hemodialysis
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 350
Sponsor: Xeltis
Summary
A prospective, single arm, non-randomized Post Market Clinical Follow-up (PMCF) registry study to evaluate the safety and performance of the aXess Hemodialysis Conduit, called aXess4All. Intended for Patients older than 18 years of age with end-stage renal disease who require a vascular access for hemodialysis, compliant with the Instructions for Use who consented in study participation.
Eligibility Criteria
Patients older than 18 years of age with end-stage renal disease who require a vascular access for hemodialysis, compliant with the Instructions for Use who consented in study participation.
Source: ClinicalTrials.gov (NCT07925502). StuddyBuddy aggregates publicly available trial information.
